XTNT
Xtant Medical Holdings Inc
NYSE MKT: XTNT · HEALTHCARE · MEDICAL DEVICES
$0.52
-3.93% today
Updated 2026-04-30
Market cap
$74.07M
P/E ratio
17.63
P/S ratio
0.55x
EPS (TTM)
$0.03
Dividend yield
—
52W range
$0 – $1
Volume
0.1M
Xtant Medical Holdings Inc (XTNT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $459229.00 | $7.39M | $15.42M | $30.15M | $32.98M | $33.07M | $35.33M | $59.35M | $90.00M | $82.61M | $72.20M | $64.68M | $53.34M | $55.26M | $57.97M | $91.30M | $117.27M | $133.93M |
| Revenue growth (YoY) | — | +1510.0% | +108.5% | +95.6% | +9.4% | +0.3% | +6.8% | +68.0% | +51.7% | -8.2% | -12.6% | -10.4% | -17.5% | +3.6% | +4.9% | +57.5% | +28.4% | +14.2% |
| Cost of revenue | $386483.00 | $2.32M | $3.36M | $9.11M | $10.34M | $14.19M | $13.03M | $20.26M | $27.71M | $32.51M | $28.72M | $22.17M | $18.95M | $22.77M | $25.83M | $35.84M | $49.05M | $49.65M |
| Gross profit | $72746.00 | $5.08M | $12.05M | $21.04M | $22.64M | $18.89M | $22.30M | $39.08M | $62.29M | $50.10M | $43.49M | $42.52M | $34.39M | $32.49M | $32.14M | $55.47M | $68.22M | $84.27M |
| Gross margin | 15.8% | 68.6% | 78.2% | 69.8% | 68.7% | 57.1% | 63.1% | 65.9% | 69.2% | 60.6% | 60.2% | 65.7% | 64.5% | 58.8% | 55.4% | 60.8% | 58.2% | 62.9% |
| R&D | — | — | — | $0.00 | $0.00 | $572361.00 | $1.44M | $2.55M | $3.41M | $2.44M | $1.70M | $932000.00 | $657000.00 | $870000.00 | $915000.00 | $1.34M | $2.38M | $2.10M |
| SG&A | — | $72301.00 | $11.14M | $8.23M | $11.56M | $10.77M | $9.02M | $13.24M | $16.03M | $15.33M | $13.00M | $17.94M | $13.50M | $14.45M | $15.46M | $25.85M | $28.69M | $29.38M |
| Operating income | $-15845.00 | $-3.62M | $-8.61M | $-6.45M | $-4.94M | $-9.01M | $-6.26M | $-12.08M | $-7.55M | $-37.83M | $-60.08M | $-2.35M | $-751000.00 | $-3.85M | $-6.75M | $-10.16M | $-12.07M | $7.28M |
| Operating margin | -3.5% | -49.0% | -55.9% | -21.4% | -15.0% | -27.2% | -17.7% | -20.4% | -8.4% | -45.8% | -83.2% | -3.6% | -1.4% | -7.0% | -11.7% | -11.1% | -10.3% | 5.4% |
| EBITDA | $-15845.00 | $-2.90M | $-17.14M | $-1.09M | $-5.07M | $-7.29M | $-3.90M | $-7.09M | $61434.00 | $-29.31M | $-54.22M | $850000.00 | $1.33M | $-2.51M | $-5.43M | $5.08M | $-7.88M | $15.89M |
| EBITDA margin | -3.5% | -39.3% | -111.2% | -3.6% | -15.4% | -22.0% | -11.0% | -11.9% | 0.1% | -35.5% | -75.1% | 1.3% | 2.5% | -4.5% | -9.4% | 5.6% | -6.7% | 11.9% |
| EBIT | $-15845.00 | $-3.61M | $-17.82M | $-1.84M | $-5.85M | $-7.66M | $-4.85M | $-11.98M | $-7.18M | $-37.71M | $-59.95M | $-2.35M | $-751000.00 | $-3.85M | $-6.72M | $1.90M | $-12.10M | $10.67M |
| Interest expense | $0.00 | $513934.00 | $1.65M | $1.16M | $1.86M | $4.65M | $5.66M | $7.73M | $12.26M | $14.70M | $10.14M | $5.77M | $5.98M | $995000.00 | $1.69M | $2.94M | $4.16M | $3.67M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-15845.00 | $-4.13M | $-19.47M | $-3.01M | $-7.71M | $-12.69M | $-10.51M | $-2.17M | $-19.49M | $-52.41M | $-70.10M | $-8.22M | $-7.02M | $-4.85M | $-8.48M | $660000.00 | $-16.45M | $4.97M |
| Net income growth (YoY) | — | -25938.1% | -371.9% | +84.6% | -156.6% | -64.6% | +17.2% | +79.3% | -796.5% | -168.9% | -33.7% | +88.3% | +14.6% | +31.0% | -75.0% | +107.8% | -2592.3% | +130.2% |
| Profit margin | -3.5% | -55.8% | -126.3% | -10.0% | -23.4% | -38.4% | -29.7% | -3.7% | -21.7% | -63.4% | -97.1% | -12.7% | -13.2% | -8.8% | -14.6% | 0.7% | -14.0% | 3.7% |